Imaging & Biomarker Correlates on Outcomes in a Phase II Trial of Neoadjuvant Gemcitabine/Nab-Paclitaxel and Hypofractionated Image-Guided Radiotherapy (HIGRT) in Potentially Resectable Pancreas Cancer

Authors :: Gerard C. Blobe
Christopher G. Willett
Dan G. Blazer
C.L. Kent
Hope E. Uronis
E. Duffy
Donna Niedzwiecki
S.J. Stephens
Brian G. Czito
Daniele Marin
Mary Malicki
Manisha Palta
James L. Abbruzzese
Source :: International Journal of Radiation Oncology*Biology*Physics. 105:E238-E239
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
Imaging biomarker
business.industry
Cancer
medicine.disease
Image guided radiotherapy
Gemcitabine
medicine.anatomical_structure
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
Pancreas
business
medicine.drug
Nab-paclitaxel

Full Text Access

Tools